“Ultrastructural changes of platelets in COVID-19 and chronic viral hepatitis patients “

References

• El Filaly H, Mabrouk M, Atifi F, Guessous F, Akarid K, Merhi Y, Zaid Y. Dissecting platelet’s role in viral infection: A double-edged effector of the immune system. Int J Mol Sci. 2023;24(3):2009. doi:10.3390/ijms24032009.
   PubMed Web of Science ®Google Scholar
• Yeaman MR. Platelets: at the nexus of antimicrobial defence. Nat Rev Microbiol. 2014;12(6):426–437. doi:10.1038/nrmicro3269.
   PubMed Web of Science ®Google Scholar
• Assinger A. Platelets and infection – an emerging role of platelets in viral infection. Front Immunol. 2014;5:649. doi:10.3389/fimmu.2014.00649.
   PubMed Web of Science ®Google Scholar
• Guo L, Rondina M. The era of thrombo-inflammation: Platelets are dynamic sensors and effector cells during infectious diseases. Front Immunol. 2019;10:2204. doi:10.3389/fimmu.2019.02204.
   PubMed Web of Science ®Google Scholar
• Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190:62. doi:10.1016/j.thromres.2020.04.014.
   PubMed Web of Science ®Google Scholar
• Koupenova M, Corkrey H, Vitseva O, et al. The role of platelets in mediating a response to human influenza infection. Nat Commun. 2019;10(1):17–26. doi:10.1038/s41467-019-09607-x.
   PubMedGoogle Scholar
• Milka K, Jane E. Platelets and COVID-19, inflammation, hyperactivation and additional questions. Circ Res. 2020;127:1419–1421. doi:10.1161/CIRCRESAHA.120.318218.
   PubMed Web of Science ®Google Scholar
• Meaghan E, Yogendra K. COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med. 2020;25(5):471–478. doi:10.1177/1358863X20932640.
   PubMed Web of Science ®Google Scholar
• Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin North Am. 2019;33(4):1045–1062. doi:10.1016/j.idc.2019.08.004.
   PubMed Web of Science ®Google Scholar
• Schrottmaier WC, Schmuckenschlager A, Pirabe A, Assinger A. Platelets in Viral Infections – Brave Soldiers or Trojan Horses. Front Immunol. 2022;13:856713. doi:10.3389/fimmu.2022.856713.
   PubMed Web of Science ®Google Scholar
• Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium infection and dysregulation by SARS-CoV-2: evidence and caveats in COVID-19. Viruses. 2020;13(1):29. doi:10.3390/v13010029.
   PubMed Web of Science ®Google Scholar
• Tyagi T, Jain K, X GS, Qiu M, Gu VW, Melchinger‎ H, Rinder H, Martin KA, Gardiner EE, Lee AI, Ho Tang W, Hwa J. A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences. Nat Cardiovasc Res. 2022;1(3):223–237. doi:10.1038/s44161-022-00021-z.
   PubMedGoogle Scholar
• Dahal S, Upadhyay S, Banjade R, Dhakal P, Khanal N, Bhatt VR. Thrombocytopenia in patients with chronic hepatitis C virus infection. Mediterr J Hematol Infect Dis. 2017;9(1):e2017019. doi:10.4084/mjhid.2017.019.
   PubMedGoogle Scholar
• Kovalic A, Satapathy S, Thuluvath P. Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis. Hepatol Int. 2020;14(5):612–620. doi:10.1007/s12072-020-10078-2.
   PubMed Web of Science ®Google Scholar
• Yu Y, Li X, Wan T. Effects of hepatitis B virus infection on patients with COVID-19: A meta-analysis. Dig Dis Sci. 2023;68(4):1615–1631. doi:10.1007/s10620-022-07687-2.
   PubMed Web of Science ®Google Scholar
• Choe JW, Jung YK, Yim HJ, Seo GH. Clinical effect of Hepatitis B Virus on COVID-19 infected patients: a nationwide population-based study using the health insurance review & assessment service database. J Korean Med Sci. 2022;37(4):29–35. doi:10.3346/jkms.2022.37.e29.
   PubMed Web of Science ®Google Scholar
• Tomaiuolo M, Litvinov RI, Weisel JW, Stalker TJ. Use of electron microscopy to study platelets and thrombi. Platelets. 2020;31(5):580–588. doi:10.1080/09537104.2020.1763939.
   PubMed Web of Science ®Google Scholar
• Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11):1317–1329. doi:10.1182/blood.2020007214.
   PubMed Web of Science ®Google Scholar
• Rustem K, Zhestkov AV, Alexandera V, Fedotov V. COVID-19 outcomes: drug treatment options. Bull Mod Clin Med. 2021;14(5):104–111.‏. doi:10.20969/VSKM.2021.14(5).104-111.
   Google Scholar
• NeiKe Za Zhi Z. Abnormal platelet function and ultrastructure in patients with severe viral hepatitis. Chinese PMID. 1990;29:416–8, 445.
   Google Scholar
• Rubin MH, Weston MJ, Bullock G, et al., Abnormal platelet function and ultrastructure in fulminant hepatic failure. Q J Med. 1977;46(183):339–352. PMID: 918251.
   PubMedGoogle Scholar
• Zaid Y, Puhm F, Allaeys I, et al. Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ Res. 2020;127(11):1404–1418. doi:10.1161/CIRCRESAHA.120.317703.
   PubMed Web of Science ®Google Scholar
• Comer SP, Cullivan S, Szklanna PB, et al. COVID-19 induces a hyperactive phenotype in circulating platelets. PLoS Biol. 2021;19:300–309. doi:10.1371/journal.pbio.3001109.
   Web of Science ®Google Scholar
• Hariri L, Hardin C. Covid-19, Angiogenesis, and ARDS Endotypes. N Engl J Med. 2020;383:182–183. doi:10.1056/NEJMe2018629.
   PubMed Web of Science ®Google Scholar
• Petito E, Falcinelli E, Paliani U, et al. Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019. J Infect Dis. 2021;223(6):933–944. doi:10.1093/infdis/jiaa756.
   PubMed Web of Science ®Google Scholar
• Panasiuk A, Prokopowicz D, Zak J, Matowicka-Karna J, Osada J, Wysocka J. Activation of blood platelets in chronic hepatitis and liver cirrhosis P-selectin expression on blood platelets and secretory activity of beta-thromboglobulin and platelet factor-4. Hepatogastroenterology. 2001;48:818–822.
   PubMed Web of Science ®Google Scholar
• Ferroni P, Mammarella A, Martini F, et al. Increased soluble P-selectin levels in hepatitis C virus-related chronic hepatitis: correlation with viral load. J Investig Med. 2001;49(5):407–412. doi:10.2310/6650.2001.33785.
   PubMed Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi:10.1007/s00134-020-06062-x.
   PubMed Web of Science ®Google Scholar
• Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021;88(1):15–27. doi:10.1159/000512007.
   PubMed Web of Science ®Google Scholar
• Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J Med Virol. 2020;92(10):1733–1734. doi:10.1002/jmv.25819.
   PubMed Web of Science ®Google Scholar
• Boeckmans J, Rodrigues RM, Demuyser T, Piérard D, Vanhaecke T, Rogiers V. COVID-19 and drug-induced liver injury: a problem of plenty or a petty point? Arch Toxico. 2020;94(4):1367–1369. doi:10.1007/s00204-020-02734-1.
   PubMed Web of Science ®Google Scholar
• Chen F, Chen W, Chen J, et al. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases. Ann Hepatol. 2021;21:100–125. doi:10.1016/j.aohep.2020.09.011.
   Web of Science ®Google Scholar
• El-Khaiat MM, El-Lehlah AM, Kesheita MA, Abdel-Samiee M, Teima AAA. Association between thrombocytopenia and the severity of Covid-19 infection among hospitalized Egyptian patients. Ann Med Surg (Lond). 2022;79:103–109. doi:10.1016/j.amsu.2022.103973.
   Web of Science ®Google Scholar
• Yang X, Yang Q, Wang Y, et al. Thrombocytopenia and its association with mortality in patients with COVID-19. J Thromb Haemost. 2020;18(6):1469–1472. doi:10.1111/jth.14848.
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort study. Platelets. 2020;31(4):490–496. doi:10.1080/09537104.2020.1754383.
   PubMed Web of Science ®Google Scholar
• Sadeghi-Haddad-Zavareh M, Bayani M, Shokri M, et al. C-Reactive protein as a prognostic indicator in COVID-19 patients. Interdiscip Perspect Infect Dis. 2021;2021:555–565. doi:10.1155/2021/5557582.
   Google Scholar
• Lippi G, Plebani M, Henry B. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145–148. doi:10.1016/j.cca.2020.03.022.
   PubMed Web of Science ®Google Scholar
• Liu R, Zhao L, Cheng X, et al. Clinical characteristics of COVID-19 patients with hepatitis B virus infection - a retrospective study. Liver Int. 2021;41(4):720–730. doi:10.1111/liv.14774.
   PubMed Web of Science ®Google Scholar
• Ronderos D, Omar AMS, Abbas H, et al. Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality. World J Clin Cases. 2021;9(29):8749–8762. doi:10.12998/wjcc.v9.i29.8749.
   PubMed Web of Science ®Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006.
   PubMed Web of Science ®Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi:10.1093/cid/ciaa248.
   PubMed Web of Science ®Google Scholar
• Negm EM. Does mass management of chronic hepatitis C protect the Egyptian population against fulminant coronavirus disease-2019? “Postulating a hypothesis”. Egypt J Bronchol. 2022;16(1):19. doi:10.1186/s43168-022-00120-2. Epub 2022 Mar 29. PMCID: PMC8961476.
   Google Scholar
• Shehata R, Zareh E, Moustafa E, Elkhyat M, Makhlof N. Impact of treatment of chronic HCV patients by direct acting antiviral drugs (DAADs) on COVID-19 disease frequency and severity. Afro-Egyptian J Infect Endemic Dis. 2023;13:225–239. doi:10.21608/aeji.2023.210472.1290.
   Google Scholar